Show Summary Details
Page of

Comorbidity of Anxiety and Depression 

Comorbidity of Anxiety and Depression
Chapter:
Comorbidity of Anxiety and Depression
Author(s):

Amanda W. Calkins

, Andrew H. Rogers

, Allison A. Campbell

, and Naomi M. Simon

DOI:
10.1093/med/9780199395125.003.0021
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 August 2020

Anxiety disorders and depression co-occur quite frequently, with as many as 60% of individuals meeting criteria for both an anxiety disorder and depression during a 12-month period. Individuals with comorbid anxiety and mood disorders have generally shown greater functional impairment, reduced quality of life, and poorer treatment outcomes compared with individuals with only one disorder. This chapter on comorbid anxiety and depression discusses the epidemiology, etiology, clinical characteristics, mechanisms, and impact of comorbid anxiety and depression, as well as methods for treating these commonly co-occurring conditions. It also highlights some of these issues for anxiety disorders comorbid with bipolar disorder. Novel treatments focused on common disorder mechanisms and future directions for improved classification of these comorbid conditions are also discussed.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.